Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8+ killer T cells

Journal of Experimental Medicine

Volumn 193, Issue 3, 2001, Pages 405-411

  Subklewe, Marion ^a   Paludan, Casper ^a   Tsang, Ming L ^a   Mahnke, Karsten ^a   Steinman, Ralph M ^a   Münz, Christian ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cross presentation; Cytotoxic T lymphocytes; Dendritic cells; Epstein Barr virus; Latency antigens

Indexed keywords

CD8 ANTIGEN; GENE PRODUCT; LATENT MEMBRANE PROTEIN 1;

APOPTOSIS; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EPSTEIN BARR VIRUS; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOGENICITY; KILLER CELL; LYMPHOCYTE TRANSFORMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PHAGOCYTOSIS; PRIORITY JOURNAL; SUPPRESSOR CELL; VIRUS LATENCY; VIRUS PARTICLE;

ANTIGEN PRESENTATION; APOPTOSIS; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CROSS REACTIONS; DENDRITIC CELLS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; NECROSIS; PHAGOCYTOSIS; VIRAL MATRIX PROTEINS; VIRUS LATENCY;

EID: 0035808781     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.193.3.405     Document Type: Article

References (28)

1. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
2. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
3. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
4. + T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1
5. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells
6. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation
7. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells
8. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes
9. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells
10. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line
11. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids
12. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus
13. Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2
14. Epstein-Barr virus. 3rd ed.
15. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas
16. + T cells
17. + T lymphocyte responses
18. Cellular peptide composition governed by major histocompatibility complex class I
19. EBV persistence in memory B cells in vivo
20. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals
21. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies
22. +, interferon-γ-secreting, T lymphocytes
23. Epstein-Barr virus and its replication. 3rd ed.
24. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines
25. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
26. + T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing
27. + T cell response: Lessons from the EBV nuclear antigen EBNA1
28. + T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function